Furthermore, several studies have indicated that DCLK1 is frequently overexpressed not only in colorectal cancer (CRC) but also in many other cancers, including hepatocellular, pancreatic, and lung cancers, in which the expression level of DCLK1 is increased with worsening severity of dysplasia 7-10. This evidence concerns the gene DCLK1 and lung carcinoma.